Although serum CK‐18 had the highest individual predictive power among those three biomarkers, serum miR‐122 has promise due to the converging evidence that it is exported from the liver during the progression of MASLD in rodent models, adults, and as we now show, in adolescents. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.